Alpha Mannosidosis Market

Alpha Mannosidosis Market (Treatment - Bone Marrow Transplant (BMT) and Enzyme Replacement Therapy (ERT); Indication - Type I, Type II and Type III; End Users - Hospitals and Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

  • Rep Id : TMRGL2501
  • Published On : Jan 2017
  • No. of Pages : 109
  • Category : Pharmaceutical

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Alpha Mannosidosis Market 

4. Market Overview
     4.1. Introduction
            4.1.1. Industry Evolution / Developments
     4.2. Market Dynamics
            4.2.1. Drivers
            4.2.2. Restraints
            4.2.3. Opportunity
     4.3. Alpha Mannosidosis Market Analysis and Forecasts, 2014-2024
            4.3.1. Pricing - Actuals and Projections, 2014-2024 (US$ per Unit)
     4.4. Porter’s Five Force Analysis
     4.5. Market Outlook

5. Alpha Mannosidosis Market Analysis and Forecasts, By Treatment
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Size (US$ Mn) Forecast By Treatment
            5.4.1. Bone Marrow Transplant (BMT)
            5.4.2. Enzyme Replacement Therapy (ERT)
     5.5. Market Attractiveness By Treatment

6. Alpha Mannosidosis Market Analysis and Forecasts, By Indication
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Size (US$ Mn) Forecast By Indication
            6.4.1. Type I
            6.4.2. Type II
            6.4.3. Type III
     6.5. Market Attractiveness By Indication

7. Alpha Mannosidosis Market Analysis and Forecasts, By End-user
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Size (US$ Mn) Forecast By End-user
            7.4.1. Hospitals
            7.4.2. Specialty Clinics
     7.5. Market Attractiveness By End-user

8. Alpha Mannosidosis Market Analysis and Forecasts, By Geography
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Key Trends
     8.4. Market Size (US$ Mn) Forecast By Geography
            8.4.1. North America
            8.4.2. Europe
            8.4.3. Asia Pacific
            8.4.4. Latin America
            8.4.5. Middle East and Africa
     8.5. Market Attractiveness By End-user

9. Competition Landscape
     9.1. Market Player – Competition Matrix (By Tier and Size of companies)
     9.2. Market Share Analysis By Company (2015)
     9.3. Company Profiles 
            9.3.1. Zymenex (Chiesi Farmaceutici S.p.A.)
                     9.3.1.1 Overview
                     9.3.1.2 Financials
                     9.3.1.3 Recent Developments 
                     9.3.1.4 Strategy

List of Tables

Table No. 1 Alpha Mannosidosis Market Size (US$ Mn) Forecast, By Treatment, 2017–2024
Table No. 2 Alpha Mannosidosis Market Size (US$ Mn) Forecast, By Indication, 2017–2024
Table No. 3 Alpha Mannosidosis Market Size (US$ Mn) Forecast, By End-user, 2017–2024
Table No. 4 Alpha Mannosidosis Market Size (US$ Mn) Forecast, By Geography, 2017–2024
Table No. 5 North America Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By Treatment ,2017– 2024
Table No. 6 North America Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By Indication ,2017– 2024
Table No. 7 North America Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By End-user,2017– 2024
Table No. 8 Europe Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By Treatment ,2017– 2024
Table No. 9 Europe Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By Indication, 2017– 2024
Table No. 10 Europe Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By End-user,2017– 2024
Table No. 11 Asia Pacific Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By Treatment ,2017– 2024
Table No. 12 Asia Pacific Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By Indication ,2017– 2024
Table No. 13 Asia Pacific Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By End-user,2017– 2024
Table No. 14 Latin America Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By Treatment ,2017– 2024
Table No. 15 Latin America Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By Indication ,2017– 2024
Table No. 16 Latin America Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By End-user,2017– 2024
Table No. 17 Middle East & Africa Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By Treatment ,2017– 2024
Table No. 18 Middle East & Africa Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By Indication ,2017– 2024
Table No. 19 Middle East & Africa Alpha Mannosidosis Market Size (US$ Mn) and Forecast, By End-user,2017– 2024

List of Figures

Figure 01 Alpha Mannosidosis Market Snapshot
Figure 02 Alpha Mannosidosis Market Size (US$ Mn) and Forecast, 2017–2024
Figure 03 Alpha Mannosidosis Treatment Market Revenue (US$ Mn) and Y-o-Y growth (%), Bone Marrow Transplant (BMT) 2017–2024
Figure 04 Alpha Mannosidosis Treatment Market Revenue (US$ Mn) and Y-o-Y growth (%),Enzyme Replacement Therapy (ERT) 2017–2024
Figure 05 Alpha Mannosidosis Market Attractiveness Analysis By Treatment
Figure 06 Alpha Mannosidosis Indication Market Revenue (US$ Mn) and Y-o-Y growth (%),Type I, 2017–2024
Figure 07 Alpha Mannosidosis Indication Market Revenue (US$ Mn) and Y-o-Y growth (%),Type II, 2017–2024
Figure 08 Alpha Mannosidosis Indication Market Revenue (US$ Mn) and Y-o-Y growth (%), Type III, 2017–2024
Figure 09 Alpha Mannosidosis Market Attractiveness Analysis By Indication
Figure 10 Alpha Mannosidosis End-user Market Revenue (US$ Mn) and Y-o-Y growth (%),Hospitals, 2017–2024
Figure 11 Alpha Mannosidosis End-user Market Revenue (US$ Mn) and Y-o-Y growth (%),Specialty Clinics, 2017–2024
Figure 12 Alpha Mannosidosis Market Attractiveness Analysis By End-user
Figure 13 Alpha Mannosidosis Market Revenue (US$ Mn) and Y-o-Y growth (%), North America, 2017–2024
Figure 14 Alpha Mannosidosis Market Revenue (US$ Mn) and Y-o-Y growth (%),Europe, 2017–2024
Figure 15 Alpha Mannosidosis Market Revenue (US$ Mn) and Y-o-Y growth (%),Asia Pacific, 2017–2024
Figure 16 Alpha Mannosidosis Market Revenue (US$ Mn) and Y-o-Y growth (%),Latin America, 2017–2024
Figure 17 Alpha Mannosidosis Market Revenue (US$ Mn) and Y-o-Y growth (%),Middle East & Africa, 2017–2024
Figure 18 North America Alpha Mannosidosis Value Share Analysis, By Treatment, 2017 and 2024
Figure 19 North America Alpha Mannosidosis Value Share Analysis, By Indication, 2017 and 2024
Figure 20 North America Alpha Mannosidosis Value Share Analysis, By End-user, 2017 and 2024
Figure 21 Europe Alpha Mannosidosis Value Share Analysis, By Treatment, 2017 and 2024
Figure 22 Europe Alpha Mannosidosis Value Share Analysis, By Indication, 2017 and 2024
Figure 23 Europe Alpha Mannosidosis Value Share Analysis, By End-user, 2017 and 2024
Figure 24 Asia Pacific Alpha Mannosidosis Value Share Analysis, By Treatment, 2017 and 2024
Figure 25 Asia Pacific Alpha Mannosidosis Value Share Analysis, By Indication, 2017 and 2024
Figure 26 Asia Pacific Alpha Mannosidosis Value Share Analysis, By End-user, 2017 and 2024
Figure 27 Latin America Alpha Mannosidosis Value Share Analysis, By Treatment, 2017 and 2024
Figure 28 Latin America Alpha Mannosidosis Value Share Analysis, By Indication, 2017 and 2024
Figure 29 Latin America Alpha Mannosidosis Value Share Analysis, By End-user, 2017 and 2024
Figure 30 Middle East & Africa Alpha Mannosidosis Value Share Analysis, By Treatment, 2017 and 2024
Figure 31 Middle East & Africa Alpha Mannosidosis Value Share Analysis, By Indication, 2017 and 2024
Figure 32 Middle East & Africa Alpha Mannosidosis Value Share Analysis, By End-user, 2017 and 2024